Rituxan, prescribed for rheumatoid arthritis and certain cancers, carries a risk of infusion reactions, which can range from mild to severe and require close monitoring by a healthcare professional.
Secretary of Defense Pete Hegseth and Chairman of the Joint Chiefs of Staff Gen. Dan Caine hold a press conference on the ...